Handelsbanken Fonder AB Has $24.55 Million Holdings in Ventas, Inc. $VTR

Handelsbanken Fonder AB grew its holdings in Ventas, Inc. (NYSE:VTR) by 12.8% in the 2nd quarter, Holdings Channel reports. The fund owned 276,474 shares of the real estate investment trust’s stock after purchasing an additional 31,380 shares during the quarter. Handelsbanken Fonder AB’s holdings in Ventas were worth $24,551,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of VTR. Deutsche Bank AG boosted its stake in shares of Ventas by 0.7% in the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after purchasing an additional 27,688 shares during the period. Bank of New York Mellon Corp increased its stake in Ventas by 2.5% during the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock worth $222,000,000 after buying an additional 70,459 shares during the period. Norges Bank acquired a new position in Ventas in the 4th quarter worth $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Ventas by 7.4% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after buying an additional 92,236 shares in the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC boosted its position in Ventas by 5.8% in the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock valued at $143,305,000 after buying an additional 101,370 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Analyst Ratings Changes

VTR has been the topic of a number of analyst reports. Wells Fargo & Company lifted their target price on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. KeyCorp raised their price objective on Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Scotiabank dropped their price objective on Ventas from $95.00 to $88.00 and set a “sector perform” rating on the stock in a report on Thursday, June 18th. UBS Group upped their target price on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research note on Monday, May 4th. Finally, Weiss Ratings raised Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $97.94.

Ventas Stock Up 2.2%

VTR opened at $88.88 on Thursday. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. The stock has a market cap of $45.59 billion, a P/E ratio of 164.59, a P/E/G ratio of 2.01 and a beta of 0.69. The stock’s 50 day moving average price is $90.03 and its 200 day moving average price is $86.41.

Insider Activity

In other news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.53% of the stock is owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.